Physician profile
Mark Jank
NPI 1447242227
$2,253.38
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $44.54 · 2021: $179 · 2022: $238.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,850.32 | 2019-2021 | |
| Rxsight INC | $206.83 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $132.43 | 2019-2022 | |
| Janssen Biotech, INC. | $28.17 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $18.03 | 2021 | |
| Beaver-Visitec International, INC. | $17.60 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.